AST Comments on OPTN Policy Proposals
Tuesday, July 9, 2013
The AST recently commented on the following OPTN policy proposals:
- Proposal to Redefine the Role of the Vice-President of the Board of Directors
- Propoal to Add Serum Sodium to the MELD Score
- Proposed Changed to the OPTN Bylaws Governing Histocompatibility Labs
- Proposed Update to the HLA Equivalency Tables in Appendix 3A
- Proposal to Clarify Requirements for Independent Donor Advocates (IDA) at Living Kidney Donor Recovery Center
- Proposal to Change Pediatric Heart Allocation Policy